Corcept Therapeutics Inc (CORT)
43.93
+0.65
(+1.50%)
USD |
NASDAQ |
Sep 27, 16:00
43.98
+0.05
(+0.11%)
After-Hours: 20:00
Corcept Therapeutics Net Income (Annual): 106.14M for Dec. 31, 2023
Net Income (Annual) Chart
Historical Net Income (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 106.14M |
| December 31, 2022 | 101.42M |
| December 31, 2021 | 112.51M |
| December 31, 2020 | 106.01M |
| December 31, 2019 | 94.18M |
| December 31, 2018 | 75.41M |
| December 31, 2017 | 129.12M |
| December 31, 2016 | 8.14M |
| December 31, 2015 | -6.408M |
| December 31, 2014 | -31.38M |
| December 31, 2013 | -46.01M |
| December 31, 2012 | -38.05M |
| Date | Value |
|---|---|
| December 31, 2011 | -32.35M |
| December 31, 2010 | -25.97M |
| December 31, 2009 | -20.17M |
| December 31, 2008 | -20.06M |
| December 31, 2007 | -11.57M |
| December 31, 2006 | -24.87M |
| December 31, 2005 | -20.09M |
| December 31, 2004 | -15.54M |
| December 31, 2003 | -9.812M |
| December 31, 2002 | -18.50M |
| December 31, 2001 | -7.454M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (Annual) Range, Past 5 Years
94.18M
Minimum
2019
112.51M
Maximum
2021
104.05M
Average
106.01M
Median
2020
Net Income (Annual) Benchmarks
| Akebia Therapeutics Inc | -51.92M |
| Bioventus Inc | -156.23M |
| Bruker Corp | 427.20M |
| Catalyst Pharmaceuticals Inc | 71.41M |
| ADMA Biologics Inc | -28.24M |